Atai Beckley (ATAI) said Tuesday its common stock has been added to the Nasdaq Biotechnology Index, effective prior to market open on Dec. 22.
The index tracks the performance of a set of securities listed on Nasdaq that are classified as either biotechnology or pharmaceutical and is calculated under a modified capitalization-weighted methodology, the company said.